A multicenter, non-interventional study evaluating adherence and tolerability of prolonged-release tacrolimus (Advagraf ) in kidney transplant patients in Germany

Trial Profile

A multicenter, non-interventional study evaluating adherence and tolerability of prolonged-release tacrolimus (Advagraf ) in kidney transplant patients in Germany

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Graft-versus-host disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COMET
  • Most Recent Events

    • 30 Oct 2017 New trial record
    • 20 Oct 2017 Results published in the Clinical Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top